Free Trial
LON:EMIS

EMIS Group (EMIS) Share Price, News & Analysis

EMIS Group logo

About EMIS Group Stock (LON:EMIS)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
433,828 shs
Average Volume
675,394 shs
Market Capitalization
£1.23 billion
P/E Ratio
4,085.11
Dividend Yield
2.21%
Price Target
N/A
Consensus Rating
N/A

Company Overview

EMIS Group plc, through its subsidiaries, provides connected healthcare software and systems for healthcare professionals in the United Kingdom. It operates in two segments, EMIS Health and EMIS Enterprise. The EMIS Health segment supplies integrated care technology to national health service markets, including primary, community, acute, and social care. The EMIS Enterprise segment focuses on the B2B technology sector in the healthcare market, such as management of medicines, partner businesses, data and analytics, research and life sciences, and patient-facing services. The company offers clinical software to healthcare organizations under the EMIS brand; patient-centric medical and wellbeing information and digital front door services under the Patient brand name; GP appraisals and training services; and service management solutions to the community pharmacy market under the Pinnacle brand, as well as business intelligence tools for GP practices, federations, and commissioners. It also operates Patient.info, an online health platform that provides personalized online patient-facing services and healthcare content; Patient Access and EMIS Web; and ProScript and ProScript Connect, which enable pharmacies to manage the dispensing process and handle tasks, such as labeling and endorsing, patient records, ordering, and stock control. In addition, the company provides non-clinical ICT solutions, such as bespoke websites for healthcare professionals and other public and private sector organizations; and supplies ICT infrastructure and hosting services. The company was founded in 1987 and is headquartered in Leeds, the United Kingdom. As of October 25, 2023, EMIS Group plc operates as a subsidiary of Optum Health Solutions (UK) Limited.

Receive EMIS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EMIS Group and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EMIS Stock News Headlines

My $247 scanner for $7
Bill Poulos is cutting the price of his $247 Instant Scanner to $7 for Black Friday. It's a one-time payment that covers a full year, with no subscription and no re-bills. Every night after the close, the scanner screens nearly a thousand of America's biggest stocks. It returns a short list of qualifying setups with the exact buy price next to each one. There's nothing to install. If you decide it's not for you, you get the $7 back and keep the scanner for the year.tc pixel
See More Headlines

EMIS Stock Analysis - Frequently Asked Questions

EMIS Group plc (LON:EMIS) posted its quarterly earnings results on Wednesday, March, 14th. The company reported GBX 47.20 EPS for the quarter, beating the consensus estimate of GBX 46.30 by GBX 0.90. The business earned £160.35 million during the quarter. EMIS Group had a net margin of 17.23% and a trailing twelve-month return on equity of 23.17%.

Based on aggregate information from My MarketBeat watchlists, some other companies that EMIS Group investors own include Babcock International Group (BAB), boohoo group (BOO), BP (BP), Clinigen Group (CLIN), Essentra (ESNT), easyJet (EZJ) and Alliance Pharma (APH).

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Healthcare Technology
Sub-Industry
Healthcare Technology
Current Symbol
LON:EMIS
CIK
N/A
Fax
N/A
Employees
1,560
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 0.47
Trailing P/E Ratio
4,085.11
Forward P/E Ratio
N/A
P/E Growth
1.37
Net Income
£30.48 million
Net Margins
17.23%
Pretax Margin
N/A
Return on Equity
23.17%
Return on Assets
7.99%

Debt

Debt-to-Equity Ratio
2.96
Current Ratio
1.07
Quick Ratio
1.83

Sales & Book Value

Annual Sales
£176.86 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
21.90
Book Value
GBX 210 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
64,160,000
Free Float
N/A
Market Cap
£1.23 billion
Optionable
Not Optionable
Beta
-0.13
7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (LON:EMIS) was last updated on 10/27/2023 by MarketBeat.com Staff.
From Our Partners